Physician profile
Syed Akbarullah
NPI 1740221258
$4,026.95
in general payments reported to CMS, 2019-2025
16 companies · $1,981 in 2025
The $1,981 reported for 2025 was more than what 76% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $44.07 · 2020: $1,512 · 2021: $15.91 · 2022: $15.78 · 2023: $357 · 2024: $101 · 2025: $1,981.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,667 · Food and Beverage: $666 · Education: $106.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,667.27 |
| Food and Beverage | $665.87 |
| Education | $106.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus Corporation of The Americas | $1,697.88 | 2025 | |
| Harmony Biosciences LLC | $1,500.00 | 2020 | |
| Abbott Laboratories | $148.63 | 2023 | Thoratec Heartmate 3 Lvas Implant Kit |
| Intuitive Surgical, INC. | $140.36 | 2023 | Da Vinci Surgical System |
| Regeneron Healthcare Solutions, INC. | $139.08 | 2024-2025 | Dupixent |
| Astrazeneca Pharmaceuticals LP | $120.77 | 2023-2025 | Airsupra, Tezspire, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $50.86 | 2019-2025 | |
| Boston Scientific Corporation | $46.75 | 2019-2023 | |
| Merck Sharp & Dohme LLC | $37.91 | 2024 | Winrevair |
| Inogen, INC. | $32.25 | 2025 | |
| Amgen INC. | $27.25 | 2023 | Tezspire |
| Bayer Healthcare Pharmaceuticals INC. | $24.99 | 2024 | |
| Genzyme Corporation | $17.39 | 2025 | |
| Glaxosmithkline, LLC. | $15.65 | 2025 | Trelegy Ellipta |
| Actelion Pharmaceuticals US, INC. | $15.18 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $12.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Syed Akbarullah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.